A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate
18 Years
N/A
Both
GIST
Trial Information
A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate
This is a non-interventional trial. No active patients will participate in this study.
Only data generated from the A6181036 study will be utilized for correlational purposes. The
A6181036 study data in addition to mutational status data previously analyzed but not
collected as part of the A6181036 study in the same patient population
Inclusion Criteria:
- GIST subjects that participated in the A6181036 study that had mutational status data
analyzed.
Exclusion Criteria:
- Subjects not participating in the A6181036 study
Type of Study:
Observational
Study Design:
Time Perspective: Retrospective
Outcome Measure:
Mutational status data retrospectively accessed correlated with A6181036 clinical outcomes data in GIST subjects treated with sunitinib
Outcome Time Frame:
9 months
Safety Issue:
No
Principal Investigator
Pfizer CT.gov Call Center
Investigator Role:
Study Director
Investigator Affiliation:
Pfizer
Authority:
United States: Food and Drug Administration
Study ID:
A6181199
NCT ID:
NCT01459757
Start Date:
October 2011
Completion Date:
April 2013
Related Keywords:
- GIST
- Retrospective
- GIST
- sunitinib
- mutational
- Gastrointestinal Stromal Tumors
Name | Location |
|---|---|
| Dana-Farber Cancer Institute | Boston, Massachusetts 02115 |
| Brigham and Women's Hospital | Boston, Massachusetts 02115 |
| Seattle Cancer Care Alliance | Seattle, Washington 98109 |
| Washington Hospital Center | Washington, District of Columbia 20010 |
| University of Washington | Seattle, Washington 98195 |
| City of Hope | Duarte, California 91010 |
| Moffitt Cancer Center | Tampa, Florida 33612 |
| Oregon Health and Science University | Portland, Oregon 97201 |
| Shands Hospital at the University of Florida | Gainesville, Florida 32610 |
| Shands Cancer Hospital at the University of Florida | Gainesville, Florida 32608 |
| Davis Cancer Pavilion and Shands Medical Plaza | Gainesville, Florida 32608 |
| Masonic Cancer Center - Clinical Trials Office | Minneapolis, Minnesota 55455 |
